Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

Novel immunomodulator FTY720 is phosphorylated in rats and humans to form a single stereoisomer. Identification, chemical proof, and biological characterization of the biologically active species and its enantiomer.

Albert, Rainer, Hinterding, Klaus, Brinkmann, Volker, Guerini, Danilo, Mueller-Hartwieg, Constanze, Knecht, Helmut, Simeon, Corina, Streiff, Markus, Wagner, Beatrix, Welzenbach, Karl, Zecri, Frederic, Zollinger, Markus, Cooke, Nigel Graham and Francotte, Eric (2005) Novel immunomodulator FTY720 is phosphorylated in rats and humans to form a single stereoisomer. Identification, chemical proof, and biological characterization of the biologically active species and its enantiomer. Journal of Medicinal Chemistry, 48 (16). pp. 5373-5377. ISSN 0022-2623

Abstract

In vivo phosphorylation of FTY720 (1) in rats and humans resulted exclusively in the biologically active (S)-configured enantiomer, which was proven by an ex vivo o-phthaldialdehyde derivatization protocol especially elaborated for phosphates of 1. Starting from the prochiral amino alcohol 1, racemic and enantiomerically pure phosphates of 1 were synthesized. Pure enantiomers were obtained after purification of a partially protected key intermediate on an enantioselective support. The absolute stereochemistry was determined by X-ray diffraction.

Item Type: Article
Related URLs:
Additional Information: archiving not formally supported by this publisher
Related URLs:
Date Deposited: 14 Dec 2009 13:58
Last Modified: 31 Jan 2013 01:14
URI: https://oak.novartis.com/id/eprint/519

Search

Email Alerts

Register with OAK to receive email alerts for saved searches.